HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yeqian Zhu Selected Research

Transplantation

2/2021Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Yeqian Zhu Research Topics

Disease

4Myocardial Infarction
12/2022 - 01/2021
2Hypoxia (Hypoxemia)
10/2020 - 10/2020
1Fibrosis (Cirrhosis)
12/2022
1Osteoporosis
12/2022
1Myocardial Ischemia (Ischemic Heart Diseases)
02/2021
1Carcinoma (Carcinomatosis)
10/2020

Drug/Important Bio-Agent (IBA)

1fasudil (AT 877)IBA
12/2022
1Calcitonin (Calcitonin, Eel)FDA LinkGeneric
12/2022
1rho-Associated KinasesIBA
12/2022
1CateninsIBA
04/2021
1Circular RNAIBA
04/2021
1Macrophage Migration-Inhibitory FactorsIBA
02/2021
1MicroRNAs (MicroRNA)IBA
01/2021
1Proteins (Proteins, Gene)FDA Link
10/2020
1Dinoprostone (PGE2)FDA Link
10/2020
1Long Noncoding RNAIBA
10/2020
12- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA
10/2020
1Acetylcholine (Acetylcholine Chloride)FDA Link
10/2020
13- (4- methylphenylsulfonyl)- 2- propenenitrileIBA
10/2020

Therapy/Procedure

1Transplantation
02/2021